Mayne Pharma | MYX - Operating Expenses

Stock Price
2.55
Daily Change
-0.01 -0.20%
Monthly
-10.07%
Yearly
-64.70%
Q1 Forecast
2.59

Mayne Pharma reported AUD103.54M in Operating Expenses for its fiscal semester ending in June of 2024.





Operating Expenses Change Date
Ansell USD 414.45M 55.9M Jun/2025
Avita Medical AUD 29.57M 1.21M Jun/2025
Cochlear AUD 460.1M 437.1M Jun/2025
CSL USD 2.87B 2.85B Jun/2025
Healius AUD 684.9M 261.2M Dec/2024
Integral Diagnostics AUD 219.16M 66.76M Jun/2024
Medical Developments International AUD 10.02M 9.78M Jun/2025
Nanosonics AUD 47.22M 37.68M Jun/2025
Polynovo AUD 27.51M 19.08M Jun/2024
Ramsay Health Care AUD 8.72B 369.4M Jun/2025
ResMed USD 922.51M 49.28M Dec/2025
Sigma Healthcare AUD 1.68B 174.89M Dec/2024
Sonic Healthcare AUD 4.23B 2.14B Dec/2024
Telix Pharmaceuticals AUD 405.4M 26.29M Dec/2025